From CRISPR breakthroughs to AI-powered drug discovery, longevity science is moving from myth to marketplace. Host Andrew Wilkinson sits down with Alex Gunz, Portfolio Manager at Heptagon Capital, to explore how innovations in genomics, stem cells, and personalized medicine could redefine healthcare — and reshape the investment landscape. Discover why the race to extend lifespan may also unlock new long-term returns.
Show Notes: https://www.interactivebrokers.com/ca...
Campus Home: https://www.ibkr.com/campus/
Traders’ Insight: https://www.ibkr.com/campus/news
Traders’ Academy: https://www.ibkr.com/campus/courses
IBKR Quant: https://www.ibkr.com/campus/quant
IBKR Podcasts: https://www.ibkr.com/campus/podcasts
IBKR Webinars: https://www.ibkr.com/campus/webinars
IBKR API: https://www.ibkr.com/campus/api
Student Trading Lab: https://www.ibkr.com/campus/stl
IBKR Glossary: https://www.ibkr.com/campus/glossary
We are on Coursera! https://www.coursera.org/ibkr
Open an account at Interactive Brokers: https://ndcdyn.interactivebrokers.com...
Disclosure: Heptagon Capital
The document is provided for information purposes only and does not constitute investment advice or any recommendation to buy, or sell or otherwise transact in any investments. The document is not intended to be construed as investment research. The contents of this document are based upon sources of information which Heptagon Capital believes to be reliable. However, except to the extent required by applicable law or regulations, no guarantee, warranty or representation (express or implied) is given as to the accuracy or completeness of this document or its contents and, Heptagon Capital, its affiliate companies and its members, officers, employees, agents and advisors do not accept any liability or responsibility in respect of the information or any views expressed herein. Opinions expressed whether in general or in both on the performance of individual investments and in a wider economic context represent the views of the contributor at the time of preparation. Where this document provides forward-looking statements which are based on relevant reports, current opinions, expectations and projections, actual results could differ materially from those anticipated in such statements. All opinions and estimates included in the document are subject to change without notice and Heptagon Capital is under no obligation to update or revise information contained in the document. Furthermore, Heptagon Capital disclaims any liability for any loss, damage, costs or expenses (including direct, indirect, special and consequential) howsoever arising which any person may suffer or incur as a result of viewing or utilising any information included in this document.
The document is protected by copyright. The use of any trademarks and logos displayed in the document without Heptagon Capital’s prior written consent is strictly prohibited. Information in the document must not be published or redistributed without Heptagon Capital’s prior written consent.
Heptagon Capital LLP, 63 Brook Street, Mayfair, London W1K 4HS
tel +44 20 7070 1800
fax +44 20 7070 1881
email [email protected]
Partnership No: OC307355 Registered in England and Wales Authorised & Regulated by the Financial Conduct Authority
Disclosure: Interactive Brokers
The analysis in this material is provided for information only and is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad-based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation by IBKR to buy, sell or hold such investments. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.
The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Interactive Brokers, its affiliates, or its employees.
Информация по комментариям в разработке